The Future...

[Guest guest]

Hi All,

I am based in the UK and recently attended a CML conference day for patients and

carers.

The Dr's that were speaking eluded to the fact that CML is now a flooded market

for treatment and that with the 1st and 2nd generation drugs available there

probably wouldn't be a 3rd anytime soon (because of the small market possibly

requiring a 3rd generation).

For example, a recent trial showing that a drug that worked well on the T3151

mutation has been shelved by the drug company due to the small market vs. the

investment required to convert it from a treatment requiring a 24hr drip to a

tablet.

I was just wondering what the views were of people 'across the pond' and beyond?

In addition to this, does the above show that the possibility of 'a safe cure'

is no longer on anybody's radar?

I was diagnosed on 9/9/09 and have reduced from 100% to 32% BCR-ABL in 5 weeks.

Please do not think that I am ungrateful for Gleevic, I really am, it was just a

question I wanted to hear alternative views about.

Thanks